» Articles » PMID: 2566394

Distribution of Beta-adrenergic Receptors in Failing Human Myocardium. Implications for Mechanisms of Down-regulation

Overview
Journal Circulation
Date 1989 Jun 1
PMID 2566394
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The density of beta-adrenergic receptors is reduced in crude membranes prepared from failing human myocardium. We used quantitative autoradiography of radioligand binding sites in intact tissue slices to determine whether the total tissue content of receptors is reduced and to characterize the transmural distribution of receptors in cardiac myocytes and the coronary vasculature in hearts obtained from nine cardiac transplant patients with severe congestive failure. Binding of [125Iodo]cyanopindolol to transmural slices of human myocardium was rapid, saturable, stereoselective, and displaceable by agonists and antagonists with an appropriate rank order of potency. Binding isotherms in four normal and nine failing ventricles showed a significant reduction in the total tissue content of beta-receptors in failing myocardium (38.3 +/- 2.0 fmol/mg protein) compared with normal tissue (52.4 +/- 1.7 fmol/mg protein, p = 0.038). In the normal ventricles, the greatest receptor density was observed autoradiographically in myocytic regions of the subendocardium. Receptor density of the coronary arterioles was approximately 70% of that in adjacent myocytic regions. The density of binding sites in both myocytic regions and arterioles was diminished in all regions of the failing ventricles, but down-regulation was due primarily to a selective reduction of beta-receptors of subendocardial myocytes (63 +/- 5% of subepicardial receptor density vs. 115 +/- 6% in controls, p less than 0.0001). These observations indicate that down-regulation occurs nonuniformly in the transmural distribution and thus is likely not related simply to elevated circulating catecholamine levels.

Citing Articles

Multiscale model of the physiological control of myocardial perfusion to delineate putative metabolic feedback mechanisms.

Gharahi H, Figueroa C, Tune J, Beard D J Physiol. 2022; 600(8):1913-1932.

PMID: 35156733 PMC: 9019727. DOI: 10.1113/JP282237.


Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling.

Nguyen V, Wu Y, Guillory A, McConnell B, Fujise K, Huang M Peptides. 2011; 33(1):77-82.

PMID: 22108711 PMC: 3396132. DOI: 10.1016/j.peptides.2011.11.010.


Cardiac receptor physiology and imaging: an update.

Chen G, Tabibiazar R, Branch K, Link J, Caldwell J J Nucl Cardiol. 2005; 12(6):714-30.

PMID: 16344234 DOI: 10.1016/j.nuclcard.2005.09.008.


Cardiac receptor physiology and its application to clinical imaging: present and future.

Tseng H, Link J, Stratton J, Caldwell J J Nucl Cardiol. 2001; 8(3):390-409.

PMID: 11391310 DOI: 10.1067/mnc.2001.115645.


Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Wang X, Dhalla N Mol Cell Biochem. 2001; 214(1-2):131-55.

PMID: 11195784 DOI: 10.1023/a:1007131925048.